The haemopoietic stem cell: Between apoptosis and self renewal

Yale Journal of Biology and Medicine

Volumn 82, Issue 1, 2009, Pages 7-18

  Alenzi, Faris Q ^a,g   Alenazi, Badi Q ^b   Ahmad, Shamweel Y ^a   Salem, Mohamed L ^c,d   Al Jabri, Ali A ^e   Wyse, Richard K H ^f  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Tanta University   (Egypt)

^e SULTAN QABOOS UNIVERSITY   (Oman)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; PROTEIN BCL 2; PROTEIN P21; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; REVIEW;

ANIMALS; APOPTOSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; REGENERATION; TISSUE ENGINEERING;

EID: 64949121713     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. McCulloch EA. Stem cells in normal and leukemic hemopoiesis. Blood. 1983;62:1-13.
2. Ploemacher R. Stem cells: characterization and measurement. Baillieres Clin Haematol. 1997;10:429-44.
3. Gordon MY. Human haemopoietic stem cell assays. Blood Rev. 1993;7:190-7.
4. Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev. 2004;14:43-7.
5. Crowe DL, Parsa B, Sinha UK. Relationships between stem cells and cancer stem cells. Histol Histopathol. 2004; 19:505-9.
6. Sikora MA, Olszewski WL. Stem cells - biology and therapeutic application. Postepy Hig Med Dosw. 2004;58:202-8.
7. Mayhall EA, Paffett-Lugassy N, Zon LI. The clinical potential of stem cells. Curr Opin Cell Biol. 2004;16:713-20.
8. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004;23:7274-82.
9. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif. 2003;36:59-72.
10. Galderisi U, Cipollaro M, Giordano A. Stem cells and brain cancer. Cell Death Differ. 2006;13:5-ll. Epub 2005 Aug 26.
11. Gordon MY, Blackett NM. Routes to repopulation - a unification of the stochastic model and separation of stem-cell subpopulations. Leukemia. 1994;8:1068-72.
12. Novak JP, Stewart CC. Stochastic versus deterministic in haemopoiesis: what is what? Br J Haematol. 1991;78:149-54.
13. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993;81:2844-53.
14. Morrison SJ, Shah NM, Anderson DJ. Regulatory mechanisms in stem cell biology. Cell. 1997;88:287-98.
15. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA. 1992;87:2804-8.
16. Craig W, Kay R, Cutler RL, Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med. 1993;177:1331-42.
17. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM. Characterization and partial purification of human marrow cells capable of initiating long term hematopoiesis in vitro. Blood. 1989;74:1563.
18. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990;75:2417-26.
19. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood. 1996;87:1-13
20. Fackler MJ, Krause DS, Smith OM, Civin CI, May WS. Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of Ml cells. Blood. 1995;85:3040-7.
21. Baumhueter S, Dybdal N, Kyle C, Lasky LA. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood. 1994;8:2554-65.
22. Suzuki A, Andrew DP, Gonzalo JA, Fukumoto M, Spellberg J, Hashiyama M, et al. CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein. Blood. 1996;87:3550-62.
23. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lympho-hematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273:242-5.
24. Sackstein R. Expression of an L-selectin ligand on hematopoietic progenitor cells. Acta Haematol. 1997;97:22-8.
25. Coulombel L, Auffray I, Gaugler MH, Rosemblatt M. Expression and function of integrins on hematopoietic progenitor cells. Acta Haematol. 1997;97:13-21.
26. Deguchi T, Komada Y, Sugiyama K, Zhang XL, Azuma E, Yamamoto H, Sakurai M. Expression of homing-associated cell adhesion molecule (H-CAM/CD44) on human CD34+ hematopoietic progenitor cells. Exp Hematol. 1999;27:542-52.
27. Gordon MY, Marley SB, Lewis JL, Davidson RJ, Nguyen DX, Grand FH, et al. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocytemacrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM. J Clin Invest. 1998;102:710-5.
28. Metcalf D. Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science. 1991;254:529-33.
29. Eaves AC, Eaves CJ. Erythropoiesis in culture. Clin Haematol. 1984;13:371-91
30. Hoffman R. Regulation of megakaryocytopoiesis. Blood. 1989;74:1196.
31. Gordon MY, Amos TA. Stochastic effects in hemopoiesis. Stem Cells. 1994;12:175-9.
32. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiation Research. 1961;14:213.
33. Humphries RK, Eaves AC, Eaves CJ. Selfrenewal of hemopoietic stem cells during mixed colony formation in vitro. Proc Natl Acad Sci USA. 1981;78:3629-33.
34. Nakahata T, Ogawa M. Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies. Proc Natl Acad Sci USA. 1982;79:3843-7.
35. Abkowitz JL, Catlin SN, Guttorp P. Evidence that hematopoiesis may be a stochastic process in vivo. Nat Med. 1996;2:190-7.
36. Nicola NA, Johnson GR. The production of committed hemopoietic colony-forming cells from multipotential precursor cells in vitro. Blood. 1982;60:1019-29.
37. Morrison SJ, Weissman IL. The long term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1994;l:661-73.
38. Metcalf D. Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation. Blood. 1998;92:345-7.
39. Enver T, Heyworth CM, Dexter TM. Do stem cells play dice? Blood. 1998;92:348-51.
40. Siminoyitch L, McCulloch A, Till JE. The identification of colony-forming cells among spleen colonies. J Cell Comp Physiol. 1963;62:327.
41. Metcalf D. Regulator-induced suppression of myelomonocytic leukemic cells: clonal analysis of early cellular events. Int J Cancer. 1982;30:203-10.
42. Lewis JL, Marley SB, Blackett NM, Szydlo R, Goldman JM, Gordon MY. Interleukin 3 (IL-3), but not stem cell factor (SCF) increases self-renewal by human erythroid burst-forming units (BFU-E) in vitro. Cytokine. 1998;10:49-54
43. Lewis JL, Marley SB, Davidson RJ, Nguyen DX. Chinswangwatanakul W, Goldman JM, Gordon MY. Protein tyrosine kinase receptor signalling decreases progenitor cell self replication. Br J Haematol. 1998;102:23.
44. Han Z, Caen J. Cytokines acting on committed haematopoietic progenitors. Baillieres Clin Haematol. 1994:7:65.
45. Quesenberry PJ. The blueness of stem cells. Exp Hematol. 1991;19:725-8.
46. Lowry PA. Botanical musings. Exp Hematol. 1992;20:540.
47. Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA. 1997;94:4080-5
48. Ferrari G, Cusella De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998;279:1528-30.
49. Till JE, McCulloch EA, Siminovitch L. A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming units. Proc Natl Acad Sci USA. 1964;51:29.
50. Suda J, SudaT, Ogawa M. Analysis of differentiation of mouse hemopoietic stem cell in cultures by sequential replating of paired progenitors. Blood. 1983;64:393.
51. Jankovic GM, Colovic MO, Petrovic MO, Rolovic ZN, Janosevic S. The stochastic blueness of leukemic stem cells in experimental antineoplastic therapy. Exp Hematol. 1993;21:1399-400.
52. Lewis JL, Blackett NM, Gordon MY. The kinetics of colony formation by CFU-GM in vitro. Br J Haematol. 1994;88:440-2.
53. Rolink A, Kudo A, Karasuyama H, Kikuchi Y, Melchers F. Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. EMBO J. 1991;10:327-36.
54. Nebel A, Schaffitzel E, Hertweck M. Aging at the interface of stem cell renewal, apoptosis, senescence, and cancer. Sci Aging Knowl Environ. 2006;9:pel4.
55. Oguro H, Iwama A. Life and death in hematopoietic stem cells. Curr Opin Immunol. 2007;19:503-9.
56. Ju Z, Rudolph KL. Telomeres and Telomerase in Stem Cells during Aging and Disease. Genome Dyn. 2006;l:84-103.
57. RuzankinaY, Asare A, Brown EJ. Replicative stress, stem cells and aging. Mech Ageing Dev. 2008;129:460-6.
58. Krishnamurthy J, Sharpless NE. Stem cells and the rate of living. Cell Stem Cell. 2007;l:9-11.
59. Berthet C, Rodriguez-Galan MC, Hodge DL, Gooya J, Pascal V, Young HA, et al. Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2. Mol Cell Biol. 2007;27:5079-89.
60. Naka K, Muraguchi T, Hoshii T, Hirao A. Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. Antioxid Redox Signal. 2008;10:1883-94.
61. Miyamoto K, Miyamoto T, Kato R, Yoshimura A, Motoyama N, Suda T. FoxO3a regulates hematopoietic homeostasis through a negative feedback pathway in conditions of stress or aging. Blood. 2008;112(12):4485-93.
62. Galan-Caridad JM, Harel S, Arenzana TL, Hou ZE, Doetsch FK, Mirny LA, Reizis B. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell. 2007;129:345-57.
63. Traycoff CM, Orazi A, Ladd AC, Rice S, McMahel J, Srour EF. Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. Exp Hematol.l998;26:53-62.
64. Koury MJ. Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol. 1992;20:391-4.
65. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature. 1990;343:76-9.
66. Testa N. Erythroid progenitor cells: their relevance for the study of haematological disease. Clin Hematol. 1979;8:311-33.
67. Kikushige Y, Yoshimoto G, Miyamoto T, Iino T, Mori Y, Iwasaki H, et al. Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival. J Immunology. 2008;180:7358-67.
68. ChadwickN, Nostro MC, Baron M, Mottram R, Brady G, Buckle AM. Notch signaling induces apoptosis in primary human CD34+ hematopoietic progenitor cells. Stem Cells. 2007;25:203-10
69. Domen J, Weissman IL. Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J Exp Med. 2000;192:1707-18
70. Domen J, Cheshier SH, Weissman IL. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med. 2000;191:253-64
71. De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G, Pelosi E, et al. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood. 1999;93:796-803.
72. Alenzi FQ, Tamimi W, Al-Sebiany A, El- Nashar E, El-Tounsi E, Bamaga MS, et al. Apoptosis role of Fas/Fas Ligand System in the Regulation of Myelopoesis. YJBM. 2005;78(l):25-36.
73. Alenzi FQ, Marley SB, Chandrashekran A, Warrens A, Goldman JM, Gordon MY. Regulation of haemopoietic progenitor cell number by the Fas/FasL apoptotic mechanism. Exp Hematol. 2002;30:1428-33.
74. Alenzi FQ. Links between apoptosis, cell cycle and proliferation. Br J Biomed Sci. 2004;61:99-102.
75. De Maria R, Zeuner A, Eramo A, Domenichelli C, Bonci D, Grignani F, et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature. 1999;401:489-93.
76. Schneider E, Moreau G, Arnould A, Vasseur F, Khodabaccus N, Dy M, Ezine S. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-lpr/lpr mice. Blood. 1999;94:2613-21.
77. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature. 1997;385:637-40.
78. Traver D, Akashi K, Weissman IL, Lagasse E. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity. 1998;9:47-57.
79. Marley SB, Lewis JL, Zheng B, Davidson RJ, Alenzi FQB, Goldman JM, Gordon MY. Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid progenitor cell self-renewal kinetics. Bone Marrow Transplant. 2001;27:241-8.
80. Thiele J, Zirbes T, Lorenzen J, Kvasnicka HM, Dresbach S, Manich B, et al. Apoptosis and proliferation (PCNA labelling) in CML, a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy. J Pathol. 1997;181:316-22.
81. Selleri C, Maciejewski JP, Pane F, Luciano L, Raiola AM, Mostarda I, et al. Fas-mediated modulation of BCR-ABL in chronic myelogenous leukemia results in differential effects on apoptosis. Blood. 1998;92:981-9.
82. Hariharan IK, Adams JM, Cory S. BCR-ABL oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res. 1988;3:387-99.
83. Mandanas RA, Boswell HS, Lu L, Leibowitz D. BCR-ABL confers growth factor independence upon a murine myeloid cell line. Leukemia. 1992;6:796-800.
84. Sirard C, Laneuville P, Dick J. Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism. Blood. 1994;83:1575-85.
85. Cortez D, Kadlec L, Pendergast AM. Structural and signaling requirements for BCR- ABL-mediated transformation and inhibition of apoptosis. Mol Cell Biol. 1995;15:5531- 41.
86. Daley GQ, Baltimore D. Transfection of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemiaspecific P210 protein. Proc Natl Acad Sci USA. 1988;85:9312-6.
87. Bryder D, Ramsfjell V, Dybedal I, et al. Selfrenewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation. J Exp Med. 2001;194:941-52
88. Pearl-Yafe M, Yolcu ES, Stein J, et al. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis. Exp Hematol. 2007;35:1601-12.
89. Pearl-Yafe M, Yolcu ES, Stein J, et al. Fas ligand enhances hematopoietic cell engraft - ment through abrogation of alloimmune responses and nonimmunogenic interactions. Stem Cells. 2007;25:1448-55
90. Pearl-Yafe M, Stein J, Yolcu E, Farkas DL, Shirwan H, Yaniv I, Askenasy N. Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors. Stem Cells. 2007;25:3194-203.
91. Jacobsen SE, Ruscetti FW, Dubois CM, et al. Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: Role of colony-stimulating factor receptor modulation. J Exp Med. 1992;175:1759-72.
92. Maciejewski J, Selleri C, Anderson S, et al. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 1995;85:3183-90.
93. Selleri C, Sato T, Anderson S, et al. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol. 1995;165:538-46.
94. Lepri E, Delfino DV, Migliorati G, et al. Functional expression of Fas on mouse bone marrow stromal cells: Upregulation by tumor necrosis factor. Exp Hematol. 1998;26:1202- 8.
95. Whartenby KA, Straley EE, Kim H, Racke F, Tanavde V, Gorski KS. Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation. Blood. 2002;100:3147-54.